http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105012327-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate | 2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105012327-B |
| titleOfInvention | Purposes of the steroid saponin RCE-4 in the drug for preparing prevention or treatment tumour |
| abstract | The invention discloses a kind of purposes of steroid saponin RCE 4 that preparation is separated from pink reineckea herb in the drug for preparing prevention or treatment tumour.The separated obtained RCE 4 of the present invention has weaker cytotoxicity to normal cell, and to human liver cancer cell H 22 There is stronger cytotoxicity with HepG2；To H 22 Lotus ascites tumor and solid tumor mouse are respectively provided with significant antitumor action, and to liquid normal blood index, blood parameters and tectology without the side effect of conspicuousness；It is suitable with effect compared with the current anticarcinogen clinically used, but the advantage that toxic side effect is small. |
| priorityDate | 2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.